Results In gastric cancer, ER were detected in 62.5% and PR in 75% of the patients. In
colorectal cancer, the ER and PR were detected in 60% of the patients. The binding activity …

Receptors for oestrogen (ER) and progesterone (PR) were assayed in tissue from 17
patients with colorectal cancer and five colonic cancer cell lines using enzyme …

In this prospective study we have quantified by means of ELISA-methods the cytosolic
content of estrogen (ER) and progesterone receptors (PgR) in tumoral tissue and paired …

Estradiol receptor (ER) and progesterone receptor (PgR) were assayed in tumors from 20
patients with primary colorectal cancer. Ten of 20 tumors contained high affinity sites for 17β …

Cancerous tissue from 86 patients with primary gastric cancer were examined for the
presence of receptors for estrogen (ER) and progesterone (PgR). ER and PgR were present …

The presence of estradiol (E) and progesterone (Pg) receptors (R) has been demonstrated
also in normal and neoplastic tissues known to be hormone-independent and in particular in …

Estrogen receptors (ER) in human gastric carcinomas were examined
immunohistochemically using a specific monoclonal antibody to human ER. ER …

Estrogen receptors have been found in normal and neoplastic gastrointestinal mucosa. The
aim of our study was to verify whether the content of cytosolic estrogen receptor in normal …

The measurement of estrogen as well as progesterone receptors has been applied clinically
to predict the effectiveness of endocrine therapy in patients with breast or endometrial …

Gastric adenocarcinoma that originates from mucosal tissue invades submucosa, muscle,
and serosa in different stages. The level of progesterone receptors (PgR), estrogen …